Analyst Price Target is $7.00
▲ +152.71% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for DiaMedica Therapeutics in the last 3 months. The average price target is $7.00, with a high forecast of $8.00 and a low forecast of $6.00. The average price target represents a 152.71% upside from the last price of $2.77.
Current Consensus is
Buy
The current consensus among 2 investment analysts is to buy stock in DiaMedica Therapeutics. This Buy consensus rating has held steady for over two years.